These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1007364)

  • 1. [Fever therapy of chronic recurring erysipelas].
    Ehring F
    Z Hautkr; 1976 Dec; 51(23):999-1002. PubMed ID: 1007364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Predisposing and triggering factors in erysipelas].
    Santos I; Andrade Lima MB; Andrade Lima BP
    Med Cutan Ibero Lat Am; 1984; 12(5):399-402. PubMed ID: 6396465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of the clinical course of erysipelas].
    Suleĭmenova ZI; Turkpenbaeva GZh; Tsoĭ IG; Turkpenbaeva AZh
    Klin Med (Mosk); 1985 Jan; 63(1):125-8. PubMed ID: 3990177
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of bemitil in recurrent erysipelas].
    Ratnikova LI
    Klin Med (Mosk); 1991 Jul; 69(7):89-90. PubMed ID: 1942990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
    Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA
    Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic recurrent erysipelas with streptococcal vaccine].
    Haustein UF; Biella U; Tausch I; Knöll H
    Hautarzt; 1989 Apr; 40(4):215-21. PubMed ID: 2659550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic recurring erysipelas].
    Naseman T
    Dtsch Med Wochenschr; 1973 Apr; 98(16):846. PubMed ID: 4266620
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characteristics of the clinical course of erysipelas and various indicators of nonspecific resistance in middle-aged patients].
    Kriukova ZV; Panichkina LN; Kriukova SA
    Vestn Dermatol Venerol; 1984 Aug; (8):48-50. PubMed ID: 6485539
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphedema of the hand following recurrent erysipelas secondary to fissured irritant contact dermatitis.
    Proske S; Uter W; Schwanitz HJ
    Contact Dermatitis; 2000 Jun; 42(6):368-9. PubMed ID: 10871118
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fever treatment of acute infections, especially of the erysipelas].
    KRIEGER H
    Med Klin; 1946 Dec; 41(23):567-71. PubMed ID: 20294891
    [No Abstract]   [Full Text] [Related]  

  • 11. [The importance of local factors in recurrent erysipelas].
    Stöberl C
    Z Hautkr; 1985 May; 60(9):712, 715-8, 721-3. PubMed ID: 4013460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrent cervical erysipela occurring in an irradiated area].
    Saiag P; Goettmann S; Husson C; Roujeau JC; Revuz J; Touraine R
    Ann Dermatol Venereol; 1989; 116(11):849-50. PubMed ID: 2619185
    [No Abstract]   [Full Text] [Related]  

  • 13. [The efficacy of the ultraviolet irradiation of the blood in the combined treatment of erysipelatous inflammation].
    Potashov LV; Reshetov AV; Tone RV; Vismont VG
    Vestn Khir Im I I Grek; 1992; 149(7-8):84-8. PubMed ID: 1341376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined penicillin-streptococcal vaccine treatment of chronically recurring erysipelas].
    Tausch I; Haustein UF; Knöll H; Köhler W
    Dermatol Monatsschr; 1975 Nov; 161(11):936-42. PubMed ID: 1204905
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenesis and principles of conservative and surgical treatment of recurrent erysipelas].
    Kosenkov AN; Narenkov VM
    Khirurgiia (Mosk); 2005; (7):63-5. PubMed ID: 16196162
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pathogenetic and prognostic significance of the level of class-E immunoglobulins in erysipelas].
    Ambalov IuM; Kovalenko AP; Usatkin AV; Khomchenko LN
    Vrach Delo; 1991 Sep; (9):76-9. PubMed ID: 1759439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent erysipelas caused by group B streptococcus organisms.
    Binnick AN; Klein RB; Baughman RD
    Arch Dermatol; 1980 Jul; 116(7):798-9. PubMed ID: 6772113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erysipelas of the upper extremity following locoregional therapy for breast cancer.
    El Saghir NS; Otrock ZK; Bizri AR; Uwaydah MM; Oghlakian GO
    Breast; 2005 Oct; 14(5):347-51. PubMed ID: 15990307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of erysipelas inflammation by quantum hemotherapy].
    Talanchuk KE
    Vestn Khir Im I I Grek; 1988 Apr; 140(4):121-2. PubMed ID: 3420737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and comorbidity of erysipelas in primary care.
    Bartholomeeusen S; Vandenbroucke J; Truyers C; Buntinx F
    Dermatology; 2007; 215(2):118-22. PubMed ID: 17684373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.